home / stock / arfxf / arfxf quote
Last: | $0.102 |
---|---|
Change Percent: | -0.58% |
Open: | $0.1009 |
Close: | $0.102 |
High: | $0.108 |
Low: | $0.095 |
Volume: | 685,017 |
Last Trade Date Time: | 06/27/2022 04:36:45 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.102 | $0.1009 | $0.102 | $0.108 | $0.095 | 685,017 | 06-27-2022 |
$0.1026 | $0.1069 | $0.1026 | $0.1069 | $0.09 | 470,700 | 06-24-2022 |
$0.0975 | $0.0989 | $0.0975 | $0.0989 | $0.0887 | 655,888 | 06-23-2022 |
$0.084 | $0.07534 | $0.084 | $0.086 | $0.0728 | 723,835 | 06-22-2022 |
$0.0788 | $0.081 | $0.0788 | $0.0811 | $0.0788 | 24,000 | 06-20-2022 |
$0.0788 | $0.081 | $0.0788 | $0.0811 | $0.0788 | 24,000 | 06-17-2022 |
$0.079 | $0.075 | $0.079 | $0.079 | $0.075 | 26,980 | 06-16-2022 |
$0.0773 | $0.07605 | $0.0773 | $0.0773 | $0.0761 | 73,500 | 06-15-2022 |
$0.075 | $0.075 | $0.075 | $0.0792 | $0.075 | 120,500 | 06-14-2022 |
$0.0798 | $0.075 | $0.0798 | $0.0798 | $0.075 | 1,600 | 06-13-2022 |
$0.0769 | $0.0759 | $0.0769 | $0.0769 | $0.0732 | 30,646 | 06-10-2022 |
$0.0798 | $0.08 | $0.0798 | $0.0802 | $0.0798 | 36,000 | 06-09-2022 |
$0.0826 | $0.0839 | $0.0826 | $0.0839 | $0.082 | 20,990 | 06-08-2022 |
$0.0865 | $0.0865 | $0.0865 | $0.0865 | $0.0865 | 9,560 | 06-07-2022 |
$0.0895 | $0.08468 | $0.0895 | $0.0895 | $0.0842 | 194,571 | 06-06-2022 |
$0.0873 | $0.089 | $0.0873 | $0.089 | $0.0865 | 11,400 | 06-03-2022 |
$0.0886 | $0.0884 | $0.0886 | $0.0886 | $0.0858 | 43,564 | 06-02-2022 |
$0.0874 | $0.09225 | $0.0874 | $0.0923 | $0.0862 | 100,210 | 06-01-2022 |
$0.0897 | $0.085 | $0.0897 | $0.093 | $0.085 | 432,150 | 05-31-2022 |
$0.0895 | $0.0841 | $0.0895 | $0.09 | $0.0841 | 78,349 | 05-30-2022 |
News, Short Squeeze, Breakout and More Instantly...
Amorfix Life Sciences Ltd Company Name:
ARFXF Stock Symbol:
OTCMKTS Market:
Amorfix Life Sciences Ltd Website:
CAMBRIDGE, Massachusetts and TORONTO, Ontario, May 14, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such ...
CAMBRIDGE, Massachusetts and TORONTO, Ontario, April 30, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer&...
CAMBRIDGE, Massachusetts and TORONTO, Ontario, April 09, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc.(Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer...